Werbung
Werbung

APUS

APUS logo

Apimeds Pharmaceuticals US, Inc.

4.23
USD
Gesponsert
-0.60
-12.42%
07. Aug., 15:56 UTC -4
Geschlossen
exchange

Nach-Markt

4.90

+0.67
+15.82%

Apimeds Pharmaceuticals US, Inc. Finanzieller Schnappschuss

Markt Cap
7.39M
Beta
0.15
Gewinn pro Aktie (EPS)
-27.40
Kurs-Buchwert-Verhältnis (P/B)
0.05
Operative Marge
--
Gesamtverschuldung/Eigenkapital (D/E)
7.40%
Kurs-Gewinn-Verhältnis
--
Eigenkapitalrendite (ROE)
-54.65%
Aktuelles Verhältnis
0.90%
Freier Cash Flow
-2.08M
APUS Profil

Aktuelle Nachrichten und Prognosen

Alle anzeigen

Aktien im Trend

Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$133.11
+15.83%
Micron Technology, Inc. logo
Micron Technology, Inc.$877.57
-0.44%
Nvidia Corp logo
Nvidia Corp$223.96
+2.27%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1,212.21
-3.68%
Palantir Technologies Inc. Class A Common Stock logo
Palantir Technologies Inc. Class A Common Stock$172.01
+10.32%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$328.58
+2.83%
Advanced Micro Devices logo
Advanced Micro Devices$483.36
-1.21%
Werbung